Skip To Main Content
Jan Leon on Muck Rack

Jan Leon

As seen in: Frontiers
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Jan Leon’s profile

Articles by Jan Leon

Long-Term Safety and Efficacy of Nipocalimab in Generalized Myasthenia Gravis: Vivacity-MG3 Open-Label Extension Phase Results

|
By Morsani College, De Bleecker, Jan Leon
| Frontiers
1. Immunotherapy and Apheresis Unit, Neuroimmunology and Muscle Pathology Unit, Multiple Sclerosis Center, IRCCS Neurological Institute Foundation C. Besta, Milan, Italy, Milan, Italy 2. 2Department of Neurology, University of South Florida, Morsani College of Medicine, Tampa, FL, USA, Tampa, United States 3. Department of Neurology, Yale University, Yale School of Medicine, New Haven, CT, USA, New Haven, United States 4.
Open in Who Shared Issue with article?

Frontiers | Long-Term Safety, Tolerability, and Efficacy of Efgartigimod (ADAPT+): Interim Results From a Phase 3 Open-Label Extension Study in Participants With Generalized Myasthenia Gravis

|
By De Bleecker, Kansas City, Van Hoorick, Jan Leon
| Frontiers
Keywords: efgartigimod, Myasthenia Gravis, neonatal Fc receptor, FcRn, IgG recycling, Antibody fragment, autoantibody reduction, neonatal Fc receptor antagonist © 2023 Howard, Bril, Vu, Karam, Peric, De Bleecker, Murai, Meisel, Beydoun, Pasnoor, Guglietta, Van Hoorick, Steeland, T'joen, Utsugisawa, Verschuuren and Mantegazza. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY).
Open in Who Shared Issue with article?
Show More